Utilization of the validated Psoriasis Epidemiology Screening Tool to identify signs and symptoms of psoriatic arthritis among those with psoriasis: a cross‐sectional analysis from the US‐based Corrona Psoriasis Registry - Mease -
The Psoriasis Epidemiology Screening Tool (PEST) scores for psoriatic... | Download Scientific Diagram
The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020
Guidelines for the management of psoriasis | DermNet
The Psoriasis Epidemiology Screening Tool (PEST) scores for psoriatic... | Download Scientific Diagram
Generalized Pustular Psoriasis Clinical Study | SPEVIGO® (Spesolimab)
1. Protocol I1F-MC-B007(b) Psoriasis Study of Health Outcomes (PSoHO) – an International Observational Study of 3-Year Health
Final questionnaire: Psoriasis Epidemiology Screening Tool (PEST-bp)... | Download Scientific Diagram
Psoriasis Research Studies - Genoskin
Current Guidelines for Psoriasis Treatment: A Work in Progress | MDedge Dermatology
A sarcopenia screening test predicts mortality in hospitalized older adults | Scientific Reports
The Psoriasis Epidemiology Screening Tool (PEST) questions, which can... | Download Scientific Diagram
Psoriasis: A Comprehensive Review on the Aetiopathogenesis and Recent Advances in Long-Term Management of Patients with Plaque Psoriasis
PDF) Psoriasis epidemiology screening tool (PEST) is useful for the detection of psoriatic arthritis in the Japanese population
Guidelines for the management of psoriasis | DermNet
EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris – Part 1: treatment and monitoring recommendations - Nast - 2020 - Journal of the European Academy of Dermatology and Venereology - Wiley Online Library
Psoriasis epidemiology screening tool (PEST) is useful for the detection of psoriatic arthritis in the Japanese population | Scientific Reports
Validating the Chinese version of the psoriasis epidemiology screening tool and early arthritis for psoriatic patients questionnaires | Chinese Medical Journal
Generalized Pustular Psoriasis Clinical Study | SPEVIGO® (Spesolimab)
Dose reduction of the new generation biologics (IL-17 and IL-23 inhibitors) in psoriasis: study protocol for an international, pragmatic, multicenter, randomized, controlled, non-inferiority study—the BeNeBio study | Trials | Full Text
![Translated article] Practical Update of the Guidelines Published by the Psoriasis Group of the Spanish Academy of Dermatology and Venereology (GPs) on the Treatment of Psoriasis With Biologic Agents: Part 2—Management of](https://static.elsevier.es/multimedia/00017310/0000011300000006/v1_202206190516/S000173102200415X/v1_202206190516/en/main.assets/fx1.jpeg "Translated article] Practical Update of the Guidelines Published by the Psoriasis Group of the Spanish Academy of Dermatology and Venereology (GPs) on the Treatment of Psoriasis With Biologic Agents: Part 2—Management of")
Translated article] Practical Update of the Guidelines Published by the Psoriasis Group of the Spanish Academy of Dermatology and Venereology (GPs) on the Treatment of Psoriasis With Biologic Agents: Part 2—Management of
PSORIASIS EPIDEMIOLOGY SCREENING TOOL (PEST)
Plaque Psoriasis (PsA) Efficacy | Enbrel® (etanercept)
Treat-to-Target Approach for the Management of Patients with Moderate-to-Severe Plaque Psoriasis: Consensus Recommendations | Dermatology and Therapy
